全文获取类型
收费全文 | 35850篇 |
免费 | 2770篇 |
国内免费 | 401篇 |
专业分类
耳鼻咽喉 | 391篇 |
儿科学 | 968篇 |
妇产科学 | 955篇 |
基础医学 | 4589篇 |
口腔科学 | 588篇 |
临床医学 | 3745篇 |
内科学 | 7631篇 |
皮肤病学 | 834篇 |
神经病学 | 2416篇 |
特种医学 | 1185篇 |
外科学 | 4887篇 |
综合类 | 1201篇 |
一般理论 | 32篇 |
预防医学 | 1969篇 |
眼科学 | 1585篇 |
药学 | 2765篇 |
中国医学 | 307篇 |
肿瘤学 | 2973篇 |
出版年
2023年 | 266篇 |
2022年 | 512篇 |
2021年 | 957篇 |
2020年 | 615篇 |
2019年 | 781篇 |
2018年 | 998篇 |
2017年 | 765篇 |
2016年 | 872篇 |
2015年 | 1052篇 |
2014年 | 1382篇 |
2013年 | 1642篇 |
2012年 | 2346篇 |
2011年 | 2457篇 |
2010年 | 1413篇 |
2009年 | 1244篇 |
2008年 | 1918篇 |
2007年 | 2022篇 |
2006年 | 2006篇 |
2005年 | 1937篇 |
2004年 | 1704篇 |
2003年 | 1585篇 |
2002年 | 1417篇 |
2001年 | 1125篇 |
2000年 | 1054篇 |
1999年 | 907篇 |
1998年 | 371篇 |
1997年 | 283篇 |
1996年 | 249篇 |
1995年 | 203篇 |
1994年 | 198篇 |
1993年 | 197篇 |
1992年 | 457篇 |
1991年 | 448篇 |
1990年 | 422篇 |
1989年 | 399篇 |
1988年 | 351篇 |
1987年 | 367篇 |
1986年 | 322篇 |
1985年 | 273篇 |
1984年 | 203篇 |
1983年 | 147篇 |
1982年 | 94篇 |
1981年 | 85篇 |
1980年 | 89篇 |
1979年 | 138篇 |
1978年 | 89篇 |
1977年 | 72篇 |
1976年 | 80篇 |
1975年 | 78篇 |
1972年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Kevin Chan Forough Farrokhyar Sarah Burrow Marcin Kowalczuk Mohit Bhandari Olufemi R. Ayeni 《Canadian journal of surgery》2013,56(6):422-426
Background
The use of hip arthroscopy has been steadily rising as technology, experience and surgical education continue to advance. Previous reports of the complication rate associated with hip arthroscopy have varied. The purpose of this study was to report our experience with hip arthroscopy complications at a single Canadian institution (McMaster University).Methods
We performed a retrospective chart review of 2 hip arthroscopists at the same institution to identify patients who had undergone the index surgery and had been followed for a minimum of 6 months postoperatively. We used a standard data entry form to collect information on patient demographic and clinical characteristics, including age, sex, surgical indication and type of complication if any.Results
A total of 211 patients underwent 236 hip arthroscopies. The mean age at time of surgery was 37 ± 13 years and mean follow-up was 394 ± 216.5 days. The overall complication rate associated with hip arthroscopy was 4.2% (95% confidence interval 2.3%–7.6%). We identified 4 major and 6 minor complications.Conclusion
Overall, hip arthroscopy appears to be safe, with minor complications occurring more frequently than major ones. However, surgeons should recognize the possibility of serious complications associated with this procedure. Future research should focus on prospective designs looking for potential prognostic factors associated with hip arthroscopy complications. 相似文献993.
Ding-Cheng Chan Yow-Shan Lee Ya-Ju Wu Hsiao-Hui Tsou Cheng-Ting Chen Jawl-Shan Hwang Keh-Sung Tsai Rong-Sen Yang 《Calcified tissue international》2013,93(5):397-404
Hip fracture rates in Taiwan are among the highest in the world. The aim of this study was to describe the trends of hip fracture hospitalizations among Taiwanese elderly (aged ≥ 65 years) and the trends of antiosteoporosis medication expenditure from 1999 to 2010. We conducted an ecological study using inpatient health care-utilization data from the Department of Health, and medication expenditure data from the IMS Health, Taiwan. The International Classification of Disease, Clinical Modification, 9th version, code 820 was used to identify hip fracture hospitalizations. Medications included alendronate, calcitonin, ibandronate, raloxifene, strontium ranelate, teriparatide, and zoledronic acid. Year 2010 was assigned as the reference point for age-standardized rates, currency exchange (to the US dollar), and discount rates. Over the 12-year study period, age-standardized hip fracture hospitalizations decreased by 2.7 % annually (p for trend < 0.001) for Taiwanese elders. The decline was more obvious among those aged ≥75 years (6.1 %). However, the number of hip fracture hospitalizations increased from 14,342 to 18,023. Total hospitalization costs increased by US$0.6 ± 0.2 million annually (p for trend = 0.002); however, the per capita costs decreased by US$23.0 ± 8.0 (p for trend = 0.017). The total medication expenditure increased 7.2-fold, from US$8.1 million to US$58.9 million, accounting for an increase in the overall pharmaceutical market by fivefold, from 3.4 to 15.9 ‰ (both p for trend < 0.001). From 1999 to 2010, there was a decline in hip fracture rates among elderly Taiwanese adults with a concomitant increase in antiosteoporosis medication expenditure. 相似文献
994.
Chris H.H. Chan Andrew Hilton Graham Foster Karl M. Hawkins Nafiseh Badiei Catherine A. Thornton 《Artificial organs》2013,37(9):793-801
Infection is a clinically relevant adverse event in patients with ventricular assist device (VAD) support. The risk of infection could be linked to a reduced immune response resulting from damage to leukocytes during VAD support. The purpose of this study was to develop an understanding of leukocyte responses during the in vitro testing of VADs by analyzing the changes to their morphology and biochemistry. The VentrAssist implantable rotary blood pump (IRBP) and RotaFlow centrifugal pump (CP) were tested in vitro under constant hemodynamic conditions. Automated hematology analysis of samples collected regularly over 25‐h tests was undertaken. A new flow cytometric assay was employed to measure biochemical alteration, necrosis (7‐AAD) and morphological alteration (CD45 expression) of the circulating leukocytes during the pumping process. The results of hematology analysis show the total leukocyte number and subset counts decreased over the period of in vitro tests dependent on different blood pumps. The percentage of leukocytes damaged during 6‐h tests was 40.8 ± 5.7% for the VentrAssist IRBP, 17.6 ± 5.4% for the RotaFlow CP, and 2.7 ± 1.8% for the static control (all n = 5). Flow cytometric monitoring of CD45 expression and forward/side scatter characteristics revealed leukocytes that were fragmented into smaller pieces (microparticles). Scanning electron microscopy and imaging flow cytometry were used to confirm this. Device developers could use these robust cellular assays to gain a better understanding of leukocyte‐specific VAD performance. 相似文献
995.
996.
Wang ZK Liu J Liu C Wang FY Chen CY Zhang XH 《Journal of gastroenterology and hepatology》2012,27(10):1629-1634
Background and Aim: Gastric adenomas (GAs) are considered as premalignant lesions of gastric adenocarcinoma. The role of Wnt signaling pathway in GAs is rarely identified. In the present study, we aimed to determine whether Wnt signaling plays a role in the pathogenesis of GAs, and to clarify the mechanism of Wnt signaling in GAs. Methods: The study investigated the relationship between clinicopathological characteristics, Helicobacter pylori (Hp) infection, adenomatous polyposis coli (APC) promoter methylation, APC and β‐catenin immunohistochemistry expression and mutation status, compared with 38 gastric adenoma and periadenomatous tissues (PTs). Results: The abnormal expression of β‐catenin in PTs, low‐grade adenomas (LGAs) and high‐grade adenomas (HGAs) was 0%, 9.09% and 81.25%. For APC, immunoreactive score (IRS) was 5.50 ± 0.5 in PTs, 3.59 ± 1.4 in LGAs and 1.8 ± 2.0 in HGAs. The scores in LGAs and HGAs were significantly lower than those in PTs (P = 0.000). IRS reflected significantly reduced expression of APC in HGAs (P = 0.002). The absent expression of APC had a correlation with the expression of β‐catenin (P = 0.000). Four LGAs (18.18%) and nine HGAs (56.25%) had methylation of APC. APC promoter methylation correlated with the grade (P = 0.014) and the expression of β‐catenin and APC (P = 0.000). Genes mutation was detected in only two adenomas (5.3%). The presence of Hp in HGAs (43.8%) was significantly higher than in LGAs (13.6%) (P = 0.038). But there was no statistical correlation to growth pattern, size, APC hypermethylation and gene mutation. Conclusion: Hypermethylation of APC promoter, instead of mutations involving APC and β‐catenin, may play a role in the development and progression of GAs contributing to moderate activation of Wnt signaling. Helicobacter pylori may accelerate the progress of gastric adenoma, but the pathogenesis needs further research. 相似文献
997.
Prideaux L Kamm MA De Cruz PP Chan FK Ng SC 《Journal of gastroenterology and hepatology》2012,27(8):1266-1280
The incidence and prevalence of inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), are lower in Asia than in the West. However, across Asia the incidence and prevalence of IBD has increased rapidly over the last two to four decades. These changes may relate to increased contact with the West, westernization of diet, increasing antibiotics use, improved hygiene, vaccinations, or changes in the gut microbiota. Genetic factors also differ between Asians and the Caucasians. In Asia, UC is more prevalent than CD, although CD incidence is rapidly increasing in certain areas. There is a male predominance of CD in Asia, but a trend towards equal sex distribution for UC. IBD is diagnosed at a slightly older age than in the West, and there is rarely a second incidence peak as in the West. A positive family history is much less common than in the West, as are extra-intestinal disease manifestations. There are clear ethnic differences in incidence within countries in Asia, and an increased incidence in IBD in migrants from Asia to the West. Research in Asia, an area of rapidly changing IBD epidemiology, may lead to the discovery of critical etiologic factors that lead to the development of IBD. 相似文献
998.
Satoh M Vazquez-Del Mercado M Krzyszczak ME Li Y Ceribelli A Burlingame RW Webb TT Sobel ES Reeves WH Chan EK 《Lupus》2012,21(1):68-74
Anti-RNA polymerase III (RNAP III) antibodies are highly specific for scleroderma (SSc) and associated with diffuse SSc and renal crisis. Coexistence of anti-RNAP III and other SSc autoantibodies is rarely documented. We report three cases with coexisting anti-RNAP III and anti-U1RNP. Autoantibodies in 3829 sera from rheumatology clinics were screened by immunoprecipitation. Anti-RNAP III-positive sera were also examined by immunofluorescence and anti-RNAP III ELISA. In total, 35 anti-RNAP III-positive sera were identified by immunoprecipitation, in which three had coexisting anti-U1RNP. All three were anti-RNAP III ELISA positive. Two had anti-RNAP I dominant (vs. RNAP III) reactivity and showed strong nucleolar staining. A case with anti-U1/U2RNP (U2RNP dominant) had systemic lupus erythematosus (SLE)-SSc overlap syndrome; however, the remaining two cases had SLE without signs of SSc. All three cases of anti-RNAP III?+?U1RNP fulfilled ACR SLE criteria but none in the group with anti-RNAP III alone (p?=?0.0002). In contrast, only one case in the former group had sclerodermatous skin changes and Raynaud's phenomenon, vs. 92% with scleroderma in the latter (p?0.05). Although anti-RNAP III is highly specific for SSc, cases with coexisting anti-U1RNP are not so uncommon among anti-RNAP III positives (8%, 3/35) and may be SLE without features of SSc. 相似文献
999.
Aim To examine the effectiveness of a stage‐matched smoking cessation counselling intervention for smokers who had cardiac diseases. Methods A total of 1860 Chinese cardiac patients who smoked at least one cigarette in the past 7 days and aged 18 years or above recruited from cardiac out‐patient clinics in Hong Kong hospitals were allocated randomly to an intervention group or control group. The intervention group (n = 938) received counselling matched with their stage of readiness to quit by trained counsellors at baseline, 1 week and 1 month. The control group (n = 922) received brief counselling on healthy diet at baseline. The primary outcomes were self‐reported 7‐day and 30‐day point prevalence (PP) of tobacco abstinence at 12 months after baseline. The secondary outcome measures included biochemically validated abstinence at 12‐month follow‐up, self‐reported 7‐day and 30‐day PP abstinence and reduction of cigarette consumption by 50% at 3 and 6 months. Results By intention‐to‐treat analysis, the intervention and control groups showed no significant difference in self‐reported 7‐day PP abstinence (intervention: 26.5% versus control: 25.5%; P = 0.60) and 30‐day PP (intervention: 25.4% versus control: 24.2%; P = 0.55), biochemically validated abstinence (intervention: 6.6% versus control: 4.9%; P = 0.14) and overall quit attempts of least 24 hours (intervention: 40.3% versus control: 34.3%; P = 0.007) at the 12‐month follow‐up, adjusted for the baseline stage of readiness to quit smoking. Conclusions An intervention, based on the Stages of Change model, to promote smoking cessation in cardiac patients in China failed to find any long‐term benefit. 相似文献
1000.
目的 探讨脑卒中后吞咽功能障碍患者经皮内镜下胃造瘘术(PEG)术前各种因素与术后死亡之间的关系,评估放置PEG管的必要性.方法 52例入组患者,详细记录了PEG前各种参数及术后生存情况,并分析病例的死亡时间特点.对术前和术后的肺炎以及消化道出血情况进行比较分析.结果 52例患者随访期内总共死亡16例,其中15例(93.4%)在术后3个月内死亡.年龄和美国麻醉师协会(ASA)评分显示与死亡有独立相关性,P值分别为0.026及0.001.PEG管置放前后吸入性肺炎发生率(50.0%比34.6%)及上消化道出血的发生率(5.8%比7.7%)比较,差异无统计学意义.结论 放置了PEG管后多数死亡病例是在短期内(3个月)出现.年龄、ASA评分与卒中患者放置PEG管后的死亡风险相关.PEG并不能降低卒中患者吸入性肺炎及消化道出血的发生率. 相似文献